Monthly Archives: October 2009

Q&A with ExonHit Therapeutics’ Loïc Maurel, MD

We recently spoke with Loïc Maurel, M.D., president of ExonHit Therapeutics’ Management Board, one of the companies presenting at the Eighth Annual BIO Investor Forum: Can you describe the top priorities or upcoming milestones for your company? This year will be the first year of product commercialization for ExonHit with the launch of EHT Dx21, a blood-based diagnostic test for Alzheimer’s disease. The Company is also focused on the outlicensing of EHT 0202, ExonHit’s lead Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: ,

Weekly Blog Roundup

This week in the blogosphere there’s a lot of chatter about synthetic biology. The Columbia Journalism Review says that synthetic biology is still not a story. They cite a number of articles in a number of publications however they say, “According to a recent poll, Americans know very little about synthetic biology, which seeks to genetically engineer new forms of life or endow existing ones with novel powers. Part of that may be the press’s Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

WORLD FOOD DAY 2009: Agricultural Biotechnology’s Fight Against Hunger

Hundreds of major media outlets covered the October 15th speech given by Bill Gates’ at the annual World Food Prize Forum in Des Moines, in which Gates makes the case for biotechnology and other modern agricultural practices in the fight to end world hunger. According to Reuters, Gates said the fight to end hunger is being hurt by environmentalists who insist that genetically modified crops cannot be used in Africa. “Some people insist on an Read More >

Farmer Gene  |  1 Comment  |  Email This Post

All Your Eggs in One Basket

Biofuels Digest reported this week that DoE Secretary Chu told attendees of an alternative energy conference, “If it were up to me, I would put every cent into electric cars.” The following day, Biofuels Digest reported its own lifecycle analysis of E85 from corn and the Tesla electric car. According to the report, “cars running on E85 corn-based ethanol at the proposed new Corporate Average Fuel Economy (CAFE) standards will generate 30 percent lower CO2 Read More >

Biofuels & Climate Change  |  1 Comment  |  Email This Post
Tags: , , , , , , , ,

Inovio begins HIV clinical trial of DNA vaccine

Inovio Biomedical Corporation (NYSE Amex: INO) and the HIV Vaccine Trials Network (HVTN) initiated a phase I clinical study of Inovio’s PENNVAX™-B preventive DNA vaccine delivered using electroporation technology. The multi-center study will be conducted at several HVTN clinical sites under a protocol designated HVTN-080. The study will enroll healthy volunteers to assess the safety of and immune responses to this DNA-based vaccine delivered via in vivo electroporation. Read the release.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: ,